They discussed three critical realities:

• Sub-nationally driven national trends: why national oncology trends must be analysed from the ground up 

• Sub-national variation: how accurate segmentation highlights significant regional and provider differences in prescribing behaviour 

• Dynamic market analysis: why static data is no longer enough to achieve true visibility

   

 Solutions Director, Chris James spoke about four individual areas which are the key elements of our specialist shared data offering:

• National Market Share Perspective (Core Proposition)

• Sub-national variation in prescribing (Regimen x indication x region)

• Sub national dynamic variation in prescribing (New patient x indication x region)

• Trust level variation in prescribing (Trust vs regional vs national variation) 

   

We are going to release one of these videos weekly on this page so stay tuned